Amantadine-assembled nanostimulator enhances dimeric RBD antigen-elicited cross-neutralization against SARS-CoV-2 strains
Nano Today(2022)
摘要
•Developing a new nanostimulator to enhance dimeric RBD-elicited cross-neutralization against SARS-CoV-2 strains.•Verifying that amantadine-assembled nanostimulator (AAS) enhances host immunity by RIG-I-like receptor signaling pathway.•Highlighting the convenience and robustness of AAS application.
更多查看译文
关键词
Amantadine assembly,Dimeric RBD antigen,RLR Signaling pathway,Cross-neutralization,SARS-CoV-2
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要